Cargando…
Evaluation of the Efficacy of CD101, a Novel Echinocandin, in the Treatment of Candida auris Infection Using a Murine Model of Disseminated Candidiasis
BACKGROUND: The first case of an invasive infection caused by C. auris was reported in July of 2016. Multiple cases have since been reported with high mortality rates due to the multidrug-resistant nature of C. auris. Although C. auris shows increased susceptibility to the echinocandin class of anti...
Autores principales: | Hager, Christopher, Long, Lisa, Larkin, Emily, Ghannoum, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631443/ http://dx.doi.org/10.1093/ofid/ofx163.1214 |
Ejemplares similares
-
Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model
por: Hager, Christopher L, et al.
Publicado: (2018) -
Evaluation of the In Vitro and In Vivo Antifungal Activity of APX001A/APX001 Against Candida auris
por: Larkin, Emily, et al.
Publicado: (2017) -
CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms
por: Chandra, Jyotsna, et al.
Publicado: (2018) -
In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris
por: Hager, Christopher L., et al.
Publicado: (2018) -
Echinocandins as Biotechnological Tools for Treating Candida auris Infections
por: Cândido, Elizabete de Souza, et al.
Publicado: (2020)